Depression App Moodpath Turns One Year Old: Over 100.000 Users, more than 25.000 Electronic Referral Letters Created

MoodpathOctober 10, 2017 was the date of the World Mental Health Day. On the same day, Moodpath, the app for the early recognition of depression, has been on the market for one year. Moodpath has been downloaded by more than 100.000 users and more than 25.000 referral letters for further treatment by healthcare professionals have been created by the app. Moodpath is already the number one app for the term “depression” on the iOS App Stores in the UK, Canada, Australia, Germany, Austria, Switzerland, and the Netherlands. The user ratings are overwhelmingly positive (with an average rating of 4.7 out of 5).

The CE-certified medical app aims to improve the recognition of depression - with the help of an algorithm and the analysis of anonymous data. "To this day, 90 percent of the people affected don't get the treatment they need. According to the WHO more than 320 million people worldwide suffer from depression. And every month there are more than 30 million Google searches on this topic. There simply is no alternative to the complementary use of digital medical products like Moodpath, if we finally want to reduce the treatment gap in mental healthcare," says Felix Frauendorf, founder of Berlin-based Aurora Health, the company behind Moodpath.

The scientific validation of Moodpath is of particular importance to the founders. Three studies are currently being conducted, including one at the Free University of Berlin. Additional research projects in the United States are about to commence: "We are currently in contact with researchers and data scientists at Columbia University and Stanford. It is our goal to constantly use studies and the latest scientific findings to further develop our mobile depression screening," stresses Mark Goering, clinical psychologist and founder of Aurora Health. Moodpath will shortly expand its services to include customized daily plans. These plans are individually tailored to the needs of each user, adapt to progress made, and include psychological exercises based on cognitive behavioural therapy.

For further information, please visit:
http://www.moodpath.io

About Moodpath
Moodpath is a mobile mental health app for the detection and treatment of depression. The app includes a user-friendly screening and improvement program. Based on an algorithm the program adapts to each individual user. The app is linked to Aurora, a platform that supports mental healthcare practitioners. Moodpath connects doctors and patients with a collaborative digital infrastructure, improving efficiency, accessibility and outcome for all stakeholders in the mental healthcare system.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...